193 related articles for article (PubMed ID: 26725879)
21. Selected Engineering and Physicochemical Aspects of Systemic Drug Delivery by Inhalation.
Sosnowski TR
Curr Pharm Des; 2016; 22(17):2453-62. PubMed ID: 26818874
[TBL] [Abstract][Full Text] [Related]
22. Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.
Iqbal J; Abbasi BA; Ahmad R; Mahmood T; Ali B; Khalil AT; Kanwal S; Shah SA; Alam MM; Badshah H; Munir A
Appl Microbiol Biotechnol; 2018 Nov; 102(22):9449-9470. PubMed ID: 30219952
[TBL] [Abstract][Full Text] [Related]
23. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
Jain V; Jain S; Mahajan SC
Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
[TBL] [Abstract][Full Text] [Related]
24. Current State of Nanomedicines in the Treatment of Topical Infectious Disorders.
Thakur K; Sharma G; Singh B; Chhibber S; Katare OP
Recent Pat Antiinfect Drug Discov; 2018; 13(2):127-150. PubMed ID: 29807522
[TBL] [Abstract][Full Text] [Related]
25. Nanomedicine: magnetic nanoparticles hit the target.
Amirfazli A
Nat Nanotechnol; 2007 Aug; 2(8):467-8. PubMed ID: 18654342
[No Abstract] [Full Text] [Related]
26. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Laube BL
Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
[TBL] [Abstract][Full Text] [Related]
27. Aerosol delivery through an artificial airway.
MacIntyre NR
Respir Care; 2002 Nov; 47(11):1279-88; discussion 1285-9. PubMed ID: 12425743
[TBL] [Abstract][Full Text] [Related]
28. Targeted drug delivery to the virus-infected airway; complications and remedies.
Clarke DT; McMillan NA
Curr Drug Deliv; 2015; 12(1):86-97. PubMed ID: 25233122
[TBL] [Abstract][Full Text] [Related]
29. Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
Zhou QT; Leung SS; Tang P; Parumasivam T; Loh ZH; Chan HK
Adv Drug Deliv Rev; 2015 May; 85():83-99. PubMed ID: 25451137
[TBL] [Abstract][Full Text] [Related]
30. An approach to deposition and clearance measurements in human airways.
Scheuch G; Stahlhofen W; Heyder J
J Aerosol Med; 1996; 9(1):35-41. PubMed ID: 10160207
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticle formulations in pulmonary drug delivery.
Bailey MM; Berkland CJ
Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
[TBL] [Abstract][Full Text] [Related]
32. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
33. Regional aerosol deposition in the human airways: The SimInhale benchmark case and a critical assessment of in silico methods.
Koullapis P; Kassinos SC; Muela J; Perez-Segarra C; Rigola J; Lehmkuhl O; Cui Y; Sommerfeld M; Elcner J; Jicha M; Saveljic I; Filipovic N; Lizal F; Nicolaou L
Eur J Pharm Sci; 2018 Feb; 113():77-94. PubMed ID: 28890203
[TBL] [Abstract][Full Text] [Related]
34. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages.
Vyas SP; Quraishi S; Gupta S; Jaganathan KS
Int J Pharm; 2005 May; 296(1-2):12-25. PubMed ID: 15885451
[TBL] [Abstract][Full Text] [Related]
35. How Should Aerosols Be Delivered During Invasive Mechanical Ventilation?
Dhand R
Respir Care; 2017 Oct; 62(10):1343-1367. PubMed ID: 28874611
[TBL] [Abstract][Full Text] [Related]
36. Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics.
Dellamary L; Smith DJ; Bloom A; Bot S; Guo GR; Deshmuk H; Costello M; Bot A
J Control Release; 2004 Mar; 95(3):489-500. PubMed ID: 15023460
[TBL] [Abstract][Full Text] [Related]
37. Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.
Durymanov MO; Rosenkranz AA; Sobolev AS
Theranostics; 2015; 5(9):1007-20. PubMed ID: 26155316
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS).
Dhege CT; Kumar P; Choonara YE
Int J Pharm; 2024 May; 657():124182. PubMed ID: 38697584
[TBL] [Abstract][Full Text] [Related]
39. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
[TBL] [Abstract][Full Text] [Related]
40. Current prospects and challenges of nanomedicine delivery in prostate cancer therapy.
Gupta S; Gupta PK; Dharanivasan G; Verma RS
Nanomedicine (Lond); 2017 Dec; 12(23):2675-2692. PubMed ID: 29098929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
